Insider Trading & Ownership - Chin Mark

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Chin Mark
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-04-21
Sale
2022-04-25
12:12 pm
Pyxis Oncology Inc.PYXSChin Mark
Former Director
Director
1,745,761$3.05$5,324,5710
(Indirect)
View
2021-10-13
Purchase
2021-10-15
5:37 pm
Pyxis Oncology Inc.PYXSChin Mark
Director
312,500$16$5,000,0001,745,761
(Indirect)
View
2021-07-16
Purchase
2021-07-28
08:50 am
IMARA Inc.IMRAChin Mark
Director
1,333,333$6$7,999,9982,344,072
(Indirect)
View
2020-03-16
Purchase
2020-03-16
5:13 pm
IMARA Inc.IMRAChin Mark
Director
10% Owner
187,500$16$3,000,0001,570,015
(Indirect
Direct)
View
2019-12-13
Sale
2019-12-17
9:23 pm
Harpoon Therapeutics Inc.HARPChin Mark
Director
10% Owner
36,558$17.01$621,9902,572,359
(Indirect)
View
2019-12-06
Sale
2019-12-10
8:07 pm
Harpoon Therapeutics Inc.HARPChin Mark
Director
10% Owner
283,202$17.75$5,025,6862,608,917
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-03-08
Option Award
2024-03-11
5:22 pm
N/A
N/A
Harpoon Therapeutics Inc.HARPChin Mark
Director
424$00
(Direct)
View
2024-03-11
Disposition
2024-03-11
5:22 pm
N/A
N/A
Harpoon Therapeutics Inc.HARPChin Mark
Director
21,787$00
(Direct)
View
2024-01-01
Option Award
2024-01-03
4:30 pm
N/A
N/A
Harpoon Therapeutics Inc.HARPChin Mark
Director
1,072$012,801
(Direct)
View
2023-11-27
Option Award
2023-11-28
4:23 pm
N/A
N/A
Harpoon Therapeutics Inc.HARPChin Mark
Director
5,000$011,729
(Direct)
View
2023-10-01
Option Award
2023-10-02
5:34 pm
N/A
N/A
Harpoon Therapeutics Inc.HARPChin Mark
Director
3,035$06,729
(Direct)
View
2023-07-01
Option Award
2023-07-06
6:37 pm
N/A
N/A
Harpoon Therapeutics Inc.HARPChin Mark
Director
18,656$036,941
(Direct)
View
2023-06-22
Option Award
2023-06-23
4:29 pm
N/A
2033-06-21
Harpoon Therapeutics Inc.HARPChin Mark
Director
23,000$023,000
(Direct)
View
2023-06-15
Exercise
2023-06-15
5:00 pm
N/A
N/A
Iterum Therapeutics plcITRMChin Mark
Director
15,853$018,306
(Direct)
View
2023-06-09
Option Award
2023-06-09
6:31 pm
N/A
2033-06-08
Disc Medicine Inc.IRONChin Mark
Director
7,136$07,136
(Direct)
View
2023-04-01
Option Award
2023-04-04
5:02 pm
N/A
N/A
Harpoon Therapeutics Inc.HARPChin Mark
Director
18,285$018,285
(Direct)
View
2022-12-29
Option Award
2023-01-03
5:12 pm
N/A
2032-12-28
Disc Medicine Inc.IRONChin Mark
Director
7,000$07,000
(Direct)
View
2022-06-22
Option Award
2022-06-24
6:42 pm
N/A
2032-06-21
Harpoon Therapeutics Inc.HARPChin Mark
Director
10,167$042,309
(Direct)
View
2022-06-22
Option Award
2022-06-24
6:42 pm
N/A
2032-06-21
Harpoon Therapeutics Inc.HARPChin Mark
Director
32,142$1.442,309
(Direct)
View
2022-06-23
Exercise
2022-06-24
6:00 pm
N/A
N/A
Iterum Therapeutics plcITRMChin Mark
Director
36,798$036,798
(Direct)
View
2022-06-15
Option Award
2022-06-17
5:01 pm
N/A
N/A
Iterum Therapeutics plcITRMChin Mark
Director
237,795$0.01237,795
(Direct)
View
2022-06-02
Option Award
2022-06-03
8:19 pm
N/A
2032-06-01
IMARA Inc.IMRAChin Mark
Director
8,500$02,352,572
(Direct)
View
2022-03-31
Option Award
2022-04-04
4:15 pm
N/A
N/A
Pyxis Oncology Inc.PYXSChin Mark
Director
66,831$01,812,592
(Direct)
View
2021-10-13
Conversion
2021-10-15
5:37 pm
N/A
N/A
Pyxis Oncology Inc.PYXSChin Mark
Director
10,547,370$01,745,761
(Indirect)
View
2021-10-07
Option Award
2021-10-12
7:47 pm
N/A
2031-10-07
Pyxis Oncology Inc.PYXSChin Mark
Director
42,191$042,191
(Direct)
View

Ownership
2021-10-07
8:56 pm
N/A
N/A
Pyxis Oncology Inc.PYXSChin Mark
Director
0$01,448,986
(Indirect)
View
2021-06-29
Option Award
2021-06-30
6:41 pm
N/A
2031-06-28
IMARA Inc.IMRAChin Mark
Director
7,728$07,728
(Direct)
View
2021-06-23
Option Award
2021-06-25
4:06 pm
N/A
N/A
Iterum Therapeutics plcITRMChin Mark
Director
36,798$036,798
(Direct)
View
2021-05-04
Option Award(A)
2021-05-14
7:57 pm
N/A
2031-05-03
Harpoon Therapeutics Inc.HARPChin Mark
Director
12,605$012,605
(Direct)
View
2021-05-04
Option Award
2021-05-07
9:52 pm
N/A
2031-05-03
Harpoon Therapeutics Inc.HARPChin Mark
Director
13,184$013,184
(Direct)
View
2020-07-28
Other
2021-03-03
5:00 pm
N/A
N/A
Iterum Therapeutics plcITRMChin Mark
Director
11,857$011,857
(Direct)
View
2020-07-01
Exercise
2020-07-02
4:08 pm
N/A
N/A
Iterum Therapeutics plcITRMChin Mark
Director
5,703$011,857
(Direct)
View
2020-05-28
Option Award
2020-06-01
9:41 pm
N/A
2030-05-27
Harpoon Therapeutics Inc.HARPChin Mark
Director
13,184$013,184
(Direct)
View
2020-04-07
Other
2020-04-09
9:17 pm
N/A
2025-01-31
Iterum Therapeutics plcITRMChin Mark
Director
2,989,903$01,096,057
(Indirect)
View
2020-03-16
Option Award
2020-03-16
5:13 pm
N/A
2030-03-15
IMARA Inc.IMRAChin Mark
Director
10% Owner
15,457$01,570,015
(Direct)
View
2020-03-16
Conversion
2020-03-16
5:13 pm
N/A
N/A
IMARA Inc.IMRAChin Mark
Director
10% Owner
9,978,168$01,570,015
(Indirect)
View

Ownership
2020-03-11
6:27 pm
N/A
N/A
IMARA Inc.IMRAChin Mark
Director
10% Owner
0$01,367,058
(Indirect)
View
2020-01-21
Option Award
2020-01-23
4:53 pm
N/A
2025-01-31
Iterum Therapeutics plcITRMChin Mark
Director
1,900,000$1,900,0001,900,000
(Indirect)
View
2019-06-13
Option Award
2019-06-17
5:00 pm
N/A
N/A
Iterum Therapeutics plcITRMChin Mark
Director
5,703$05,703
(Direct)
View
2019-06-03
Option Award
2019-06-05
5:17 pm
N/A
2029-06-02
Harpoon Therapeutics Inc.HARPChin Mark
Director
10% Owner
10,167$010,167
(Direct)
View
2019-05-24
Exercise
2019-05-29
4:22 pm
N/A
N/A
Iterum Therapeutics plcITRMChin Mark
Director
6,154$01,096,057
(Direct)
View
(A) Indicate amendment filing.